Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.

about

Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.

Item

http://www.wikidata.org/entity/Q48244028

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prevalence of metabolic syndro ...... arison to conventional agents.

@en

Prevalence of metabolic syndro ...... arison to conventional agents.

@nl

type

Item

label

Prevalence of metabolic syndro ...... arison to conventional agents.

@en

Prevalence of metabolic syndro ...... arison to conventional agents.

@nl

prefLabel

Prevalence of metabolic syndro ...... arison to conventional agents.

@en

Prevalence of metabolic syndro ...... arison to conventional agents.

@nl

P1476

Prevalence of metabolic syndro ...... parison to conventional agents

@en

P2093

Dhuha Alrqobah

http://www.w3.org/2001/XMLSchema#string

Nasser Haji Hussain

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting inflammation in diabetes: Newer therapeutic options

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.

Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus

TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.

Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment.

Effects of etanercept in patients with the metabolic syndrome.

Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.

Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study.

P31

scholarly article

P356

10.1111/DTH.12566

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nawaf Al Mutairi

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29334162

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome